DexCom, Inc. (DXCM)
NASDAQ: DXCM · IEX Real-Time Price · USD
131.52
+0.81 (0.62%)
At close: Apr 22, 2024, 4:00 PM
132.49
+0.97 (0.74%)
After-hours: Apr 22, 2024, 7:59 PM EDT
DexCom Market Cap
DexCom has a market cap or net worth of $50.70 billion as of April 22, 2024. Its market cap has increased by 13.41% in one year.
Market Cap
50.70B
Enterprise Value
50.51B
1-Year Change
13.41%
Ranking
Category
Stock Price
$131.52
Market Cap Chart
Since April 14, 2005, DexCom's market cap has increased from $312.50M to $50.70B, an increase of 16,124.94%. That is a compound annual growth rate of 30.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2024 | 50.70B | 0.62% |
| Apr 19, 2024 | 50.39B | -2.67% |
| Apr 18, 2024 | 51.77B | 0.33% |
| Apr 17, 2024 | 51.61B | -1.95% |
| Apr 16, 2024 | 52.63B | 1.46% |
| Apr 15, 2024 | 51.88B | -1.16% |
| Apr 12, 2024 | 52.48B | -2.49% |
| Apr 11, 2024 | 53.83B | -0.50% |
| Apr 10, 2024 | 54.10B | -0.09% |
| Apr 9, 2024 | 54.15B | 0.36% |
| Apr 8, 2024 | 53.95B | 0.73% |
| Apr 5, 2024 | 53.56B | 4.19% |
| Apr 4, 2024 | 51.40B | -3.73% |
| Apr 3, 2024 | 53.40B | 1.36% |
| Apr 2, 2024 | 52.68B | -0.94% |
| Apr 1, 2024 | 53.18B | -0.55% |
| Mar 28, 2024 | 53.47B | -0.56% |
| Mar 27, 2024 | 53.77B | -0.32% |
| Mar 26, 2024 | 53.95B | -0.12% |
| Mar 25, 2024 | 54.01B | 5.20% |
| Mar 22, 2024 | 51.34B | -0.17% |
| Mar 21, 2024 | 51.43B | 0.66% |
| Mar 20, 2024 | 51.09B | -1.22% |
| Mar 19, 2024 | 51.72B | -0.41% |
| Mar 18, 2024 | 51.94B | 3.27% |
View and export this data all the way back to 2005.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| GSK | 80.66B |
| McKesson | 68.97B |
| Becton, Dickinson and Company | 67.64B |
| Zoetis | 67.08B |
| Edwards Lifesciences | 51.68B |
| Cencora | 47.70B |
| Takeda Pharmaceutical | 41.55B |
| IQVIA Holdings | 41.52B |